These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32271688)

  • 1. Uncertainty in the Process of Communicating Cancer-related Genetic Risk Information with Patients: A Scoping Review.
    Hong SJ
    J Health Commun; 2020 Mar; 25(3):251-270. PubMed ID: 32271688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
    Jacobs C; Patch C; Michie S
    Eur J Hum Genet; 2019 Apr; 27(4):511-524. PubMed ID: 30573802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
    Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
    Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
    Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
    J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating genetic test results to the family: a six-step, skills-building strategy.
    Daly MB; Barsevick A; Miller SM; Buckman R; Costalas J; Montgomery S; Bingler R
    Fam Community Health; 2001 Oct; 24(3):13-26. PubMed ID: 11563941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
    Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
    Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
    Dean M; Davidson LG
    Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
    Sherman KA; Kasparian NA; Mireskandari S
    Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.
    Hallowell N; Foster C; Ardern-Jones A; Eeles R; Murday V; Watson M
    Genet Test; 2002; 6(2):79-87. PubMed ID: 12215246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Our Job is that Whole Gray Zone in Between There": Investigating Genetic Counselors' Strategies for Managing and Communicating Uncertainty.
    Zhong L; Woo J; Steinhardt MA; Vangelisti AL
    Health Commun; 2020 Nov; 35(13):1583-1592. PubMed ID: 31423843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
    Dean M
    Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
    Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Centered Communication for Discussing Oncotype DX Testing.
    Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes KE; Wheeler SB
    Cancer Invest; 2016 May; 34(5):205-12. PubMed ID: 27124287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.
    Hopwood P
    Curr Opin Oncol; 2005 Jul; 17(4):340-4. PubMed ID: 15933464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
    Pasacreta JV
    Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I Am Uncertain About What My Uncertainty Even Is": Men's Uncertainty and Information Management of Their BRCA-Related Cancer Risks.
    Rauscher EA; Dean M; Campbell-Salome GM
    J Genet Couns; 2018 Dec; 27(6):1417-1427. PubMed ID: 29971606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.
    Taylor KM; Kelner MJ
    CMAJ; 1996 Apr; 154(8):1155-8. PubMed ID: 8612250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.